AC
ALKS icon

Ascend Capital’s Alkermes ALKS Stock Holding History

Ascend Capital’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-131,342
Closed -$10.4M – 99
2015
Q4 		$10.4M Buy
+131,342
New +$9.2M 0.37% 77

Other funds holding ALKS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ascend Capital's ALKS Position: Q1 2016 in Review

Ascend Capital sold out of Alkermes (ALKS) in Q1 2016, closing a stake of 131,342 shares — an estimated $10.4M sold.

Ascend Capital first reported a position in ALKS in Q4 2015 and held it in 1 quarter. The position peaked at $10.4M in Q4 2015. 242 funds tracked by Wall St. Rank hold ALKS as of Q1 2016.

  • Ascend Capital reported no remaining Alkermes position as of Q1 2016 after selling out during the quarter.
  • Ascend Capital sold 131,342 Alkermes shares in Q1 2016, an estimated $10.4M.
  • Ascend Capital first reported a position in Alkermes in Q4 2015 and held it in 1 quarter.
  • Ascend Capital's Alkermes position peaked at $10.4M in Q4 2015.
  • 242 funds tracked by Wall St. Rank held Alkermes as of Q1 2016.

Based on Ascend Capital's 13F filing for Q1 2016, filed 13 May 2016.